mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.2 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.0074 |
0.9 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.00054 |
1 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.04 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.4 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.008 |